EPLBD06	Factors associated with mental health outcomes among people living with HIV co-infected with SARS-CoV-2 in France: results from COVIDHIV study	E-poster	COVID-19: Associated mental health challenges for people living with HIV
EPF044	Drug decriminalization done right: a civil society platform	E-poster	Criminalization, incarceration and living in closed settings
PESUF14	Community-based assessment on criminalization costs in the Central and Eastern Europe, and Central Asia region	Poster exhibition	Criminalization, incarceration and living in closed settings
EPB230	The BAF complex inhibitor pyrimethamine induces HIV-1 transcription in ART-suppressed HIV-1-infected individuals	E-poster	Cure interventions
EPB231	Inhibitory, KIR/HLA-mismatched, allogeneic NK and Î³Î´-T cells as an HIV cure strategy: proof-of-concept in 3 patients	E-poster	Cure interventions
EPB232	In vitro evaluation of drug-loaded polymeric nanoparticles in the treatment of Human Immunodeficiency Virus	E-poster	Cure interventions
EPLBB08	Analytical treatment interruption (ATI) among African women with early ART initiation with or without VRC01 circulating at HIV acquisition: study design and early observations of viral rebound and control	E-poster	Cure interventions
OALBB0104	The 'City of Hope' Patient: prolonged HIV-1 remission without antiretrovirals (ART) after allogeneic hematopoietic stem cell transplantation (aHCT) of CCR5-Î?32/Î?32 donor cells for acute myelogenous leukemia (AML)	Oral abstract session with live Q&A	Cure interventions
EPB209	Joint evolution of CD4 and viral load trajectories over 2 years in an early-treated pediatric African cohort	E-poster	Cure strategies in paediatric and adolescent populations
OALBB0102	Phase I/II study of monoclonal antibody VRC01 with early antiretroviral therapy to promote clearance of HIV-1 infected cells in infants (IMPAACT 2008)	Oral abstract session with live Q&A	Cure strategies in paediatric and adolescent populations